Guias GRADE

GRADE: Higher Dose and Adjuvanted Influenza Vaccines for Persons Aged ≥65 Years

MMWR recomm. rep; 71 (1), 2022

Estimated rates of influenza-associated hospitalization and death are generally highest among individuals 65 years of age and older (1-4), an age group for whom influenza vaccine effectiveness is often lower relative to younger populations (5, 6). Two inactivated influenza vaccines approved in the U.S. f...

Vacinas contra Influenza/efeitos adversos, Influenza Humana/imunologia, Programas de Imunização, Estados Unidos

Texto completo

Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Use of Live Attenuated Influenza Vaccine (LAIV) and Inactivated Influenza Vaccine (IIV) in Children

An adaptation of Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methods [1] was used to evaluate relative benefits and harms of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) for healthy children aged 2 through 8 years. As of the 2013-14 influ...